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Introduction
Coronary artery ectasia (CAE) is a dilatation of the artery, which diameter exceeds the largest native coronary vessel by 1.5 fold [1] . The incidence of CAE varies from 0.15 to 5.3% among coronary angiographies of patients diagnosed with CAD [2] . The etiology of CAE has not been fully established yet. Lenihana et al. observed that coronary aneurysms in adults <33 years of age are typically congenital, resulting from the defect of an internal elastic membrane and fibrillar proteins of connective tissue [3] . In older age, secondary causes of CAE development dominated, such as atherosclerosis, vasculitis or angiogenesis disorders. The underlying mechanism is probably based on the compensatory enlargement of the artery lumen in the site of atherosclerotic lesions, compensating for atheromatous plaque build-up.
One of the pathophysiological factor is an immuno-inflammatory reaction as a response to endothelial injury [2, 4] . Endocan, a proteoglycan secreted by endothelium in response to inflammatory cytokines and plays a crucial role in regulating major physiologic and pathophysiologic processes, such as cell adhesion, inflammation, and tumor progression [4] .
Additionally, several readily achievable and promising inflammatory and metabolic parameters, such as mean platelet volume (MPV) [5] , neutrophils-to-lymphocytes ratio (NLR) [6] , platelets-to-lymphocytes ratio (PLR) [7] or triglyceride/ high-density lipoprotein ratio (TG/HDL) [8] were validated in other cardiac diseases, especially in ischemic heart disease.
We sought to assess the severity of inflammation and metabolic disorders in patients with CAE compared to patients with and without significant atherosclerosis using endocan and the simple inflammatory and metabolic markers.
Methods
In this study, we consecutively included 27 patients with CAE (CAE group) among patients who underwent coronary angiography for suspected CAD. Diagnosis of coronary artery ectasia was based on the conventional definition of a coronary diameter ≥ 1.5 times of the original caliber of the artery or the adjacent segment diameter. The second group consisted of 27 age-and sex-matched patients with coronary artery stenosis by >70% and without CAE (CAD group). Finally, we studied the third group of 27 age-and sex-matched participants (control group) with normal coronary arteries. From this study we excluded the patients with acute inflammatory disorders (hsCRP>10mg/l), active neoplastic disease, connective tissue diseases, thrombotic diathesis and plasmatic diathesis, acute and chronic renal failure with GFR<30ml/min, allergy to iodinated contrast medium.
Blood samples one day after coronary angiography were obtained. For blood serum collection the standard tubes with chemically neutral coagulation activator (the main component is SiO2) were used. In the serum routine laboratory parameters were determined. The remainder of the sera was aliquoted, frozen and stored at -80oC. Determination of endocan was performed by using Human Endothelial cell-specific Molecule 1(ECSM1/ENDOCAN) ELISA Kit manufactured by DRG MedTek company. The analysis was performed in the laboratory of Clinical Pharmacology.
Statistical analysis was performed with STATISTICA 12.0 (StatSoft, USA). Normality of the variables distributions was tested using the Shapiro-Wilk test. The report includes descriptive analysis, Kruskal-Wallis test, ANOVA test, Mann-Whitney U test to compare each study group. Differences with p-value<0.05 were considered statistically significant.
Results and Discussion
The baseline characteristics of the study groups are presented in Table 1 . According to these data, the prevalence of cardiovascular risk factors such as age, gender, hypertension, diabetes did not differ among the groups (for all, p>0.05). CAEs ware most often located in RCA and LAD (53.5% and 48.8%, respectively). Diffuse ectasias were significantly more frequent than localized aneurysms (60.5% vs. 33.4%, respectively). Significant stenosis of coronary arteries was diagnosed in 60.5% of patients with CAE. The level of endocene did not differ significantly among groups. However, we found significantly elevated MPV both in the atherosclerotic lesions and coronary aneurysm compared with the control group. Similairly, the metabolic disorders such as reduced HDL cholesterol, higher TG/HDL ratio, and monocyte/HDL ratio were more pronounced in CAE and CAD groups than in the control group. LDL/HDL ratio was significantly higher in CAE patients than in CAD group (Table   1) .
These several readily available and promising inflammatory parameters have been validated in cardiac diseases. An elevated level of MPV is related to increased platelet activation and, in consequence, a higher risk of thrombotic disorders, myocardial infarction, especially myocardial infarction with ST-segment elevation [5] . Chen et al. found elevated MVP also in patients with coronary aneurysms in the course of Kawasaki disease [9] . Interestingly, Bahadır Şarlı et al. revealed a significantly higher MPV only in patients with coronary artery ectasia coexisting with CAD [10] . Isolated CEA was not associated with elevated MPV as compared to the control group. The above results suggest that the inflammation contributes to the atherogenesis and the secondary-developed aneurysms. Another interesting finding was significantly lower HDL-C levels and higher TG/HDL ratio in CAE and CAD patients compared with control. Increase in TG/HDL ratio reflects the unfavorable alteration in lipid profile, which also has been linked to insulin resistance and incidents of ischemic heart disease [8] . Sudhir et al. demonstrated an increased prevalence of CAE in patients with heterozygous familial hypercholesterolemia and strong correlation between low HDL-C level and more frequent incidence of ectasias [11] . Our analysis also revealed a higher monocytes/HDL-c ratio in patients with coronary aneurysms compared to controls. Yildirim et al. found a significant increase in the adhesion of monocyte and lymphocyte in CAE patients in the comparison to CAD and controls [12] . This finding may reflect the increased intensity of inflammation and oxidative stress in CAE compared with CAD. CAE is a rare phenomenon thus the number of patients in our analysis is limited. Due to the relatively small number of patients and potentially complex etiology these findings need a further investigation.
In conclusion, the majority of aneurysms in adults coexist with significant atherosclerosis.
Almost all of the studied parameters were comparatively elevated in patients with CAE and CAD compared with the control. The most probable cause is the atherosclerotic etiology of most aneurysms. Therefore, there is still a need to investigate additional risk factors for the formation of CAE, especially in the atherosclerotic form. 
